Provider Review · 70/100 · Updated October 16, 2026
Found Review
Updated October 16, 2026 with prices and facts re-checked October 14, 2026.
Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.
#8 of 970/100no public medication price
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Price check, September 20, 2026 — read on Found’s own pages, computed from the open dataset:
Tirzepatide: no rankable compounded price on the public page — 'Cash plans from $169/mo' for the GLP-1 program, 'billed per 28-day cycle', '*Pricing based on 12-month plans paid up-front'; 'Monthly plans start at ... First-party · no pricejoinfound.com · 2026-09-17
For comparison — NexLife’s 12-month rates charged monthly: tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “last updated” date; this block is regenerated on every update.
Overview
Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.
Found meets 0 of 6 v3.0 transparency pillars. No pillars met means cohort outcomes, AE disclosure, and pharmacy traceability documentation are limited per our review.
Pricing
no public medication price. Verify final pricing directly with the provider before purchasing — prices may change.
Trade-offs to know
0 of 6 v3.0 transparency pillars met — gaps versus rubric leaders.
Verify pricing, pharmacy partners, and clinical protocol directly with Found before purchasing.
Brand-name medications are FDA-approved; compounded medications are not.
How to evaluate Found
If you're considering Found, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.
Found prints no public medication price. Its tirzepatide page shows cash plans from $169 a month, billed per 28-day cycle, with that price based on 12-month plans paid up front (read September 17, 2026).
Why does Found meet none of the six transparency pillars?
Found scores 70/100, ranked ninth of ten, but meets 0 of 6 pillars because of limited public disclosure on pharmacy and outcomes, per the site’s review.
Does Found prescribe brand-name or compounded GLP-1s?
Both. Found uses a mixed model of branded GLP-1s plus compounded options. Brand-name medications are FDA-approved; compounded medications are not, so ask which one you will receive.
How does Found’s tirzepatide price compare with NexLife’s?
Found’s cash plans start at $169 a month on 12-month plans paid up front. NexLife lists compounded tirzepatide at $139 a month on a 12-month plan charged monthly, with no membership (read October 14, 2026).
